Abbott Laboratories, the largest maker of heart stents and adult nutritional beverages, said first-quarter profit beat estimates on rising demand for diagnostic tests and reduced costs, Bloomberg reports.
$ABT CEO White: Company planning a number of key product launches across businesses in ‘14 as #pipeline delivers http://t.co/QnQLSza02P
— Abbott (@AbbottNews) April 16, 2014
Layoffs at Abbott Laboratories: report
Abbott reports weaker-than-expected 4Q revenue